Sarcoidosis, a systemic granulomatous disease of unknown etiology, likely results from an environmental insult in a genetically susceptible host. In the US, African Americans are more commonly affected with sarcoidosis and suffer greater morbidity than Caucasians. We searched for sarcoidosis susceptibility loci by conducting a genome-wide, sib pair multipoint linkage analysis in 229 African-American families ascertained through two or more sibs with a history of sarcoidosis. Using the Haseman-Elston regression technique, linkage peaks with P-values less than 0.05 were identified on chromosomes 1p22, 2p25, 5p15-13, 5q11, 5q35, 9q34, 11p15 and 20q13 with the most prominent peak at D5S2500 on chromosome 5q11 (P ¼ 0.0005). We found agreement for linkage with the previously reported genome scan of a German population at chromosomes 1p and 9q. Based on the multiple suggestive regions for linkage found in our study population, it is likely that more than one gene influences sarcoidosis susceptibility in African Americans. Fine mapping of the linked regions, particularly on chromosome 5q, should help to refine linkage signals and guide further sarcoidosis candidate gene investigation.
Introduction
Despite several attempts, including a well-designed study involving over 700 cases and matched controls (ACCESS Research Group 1999), the etiology of sarcoidosis remains unknown. Several environmental risk factors, such as bacterial infection, pine pollen, clay eating, wood dust exposure and occupational exposure to metals, silica, or talc, while previously implicated, remain unconfirmed. [1] [2] [3] [4] [5] [6] [7] [8] Age, race and gender are the most clearly defined risk factors for sarcoidosis. 9, 10 Genetic variation likely explains why granulomatous inflammation occurs in some individuals in response to the 'sarcoidosis antigen'. 11 That an inherited susceptibility to sarcoidosis exists is best supported by familial clustering. 10, 12, 13 While sarcoidosis in the US has an annual disease incidence ranging from 11 per 100 000 in Caucasians to 36 per 100 000 in African Americans, 9 firstdegree relatives of African-American sarcoidosis cases have about a three-fold increased disease risk. 10 Schurmann et al 14 reported a genome-wide search for predisposing genes in sarcoidosis. On the basis of 225 microsatellite markers tested in 63 German families (Caucasians) with affected sib pairs, linkage at the major histocompatibility complex (MHC) on chromosome 6p was found with additional suggested linkage to markers on chromosome 1, 3, 9 and X.
14 Several candidate genes from the MHC region have been investigated [15] [16] [17] with the DRB1 gene most consistently identified as a risk factor for sarcoidosis. [18] [19] [20] Replicating linkage findings in additional samples is key to unraveling the genetics of complex diseases, such as sarcoidosis. Also, candidate regions identified in one group may not play a role in others. We chose to focus on African Americans who are more commonly and severely affected, more likely to have a family history of sarcoidosis, affected at a younger age than Caucasians and less likely to be asymptomatic at presentation. 9, 21, 22 The Sarcoidosis Genetic Analysis Consortium (SAGA) was formed to ensure that a sufficient sample of affected sibling pairs could be recruited for study. We report the results of a sib pair linkage analysis of 380 microsatellite markers spanning the 22 autosomes in 229 AfricanAmerican families.
Results
The genome scan results based on Haseman-Elston (H-E) regression (516 pairs) and mean tests for affected full pairs (252 pairs) and discordant full pairs (149 pairs) are displayed in Figure 1 for each of the 22 autosomes. All results presented are multipoint which were consistent with the single point results. Based on H-E P-values for the sample including full and half-sibs, the most significant results were found on chromosome 5 with Figure 1 Genome scan results for sarcoidosis susceptibility in African-American nuclear families ascertained through two affected sibs. Results are depicted as -log to the base 10 of multipoint P-values for H-E regression (n ¼ 516 sib pairs) and separate mean tests for concordant affected full-sib pairs (n ¼ 252) and discordant affected full-sib pairs (n ¼ 149). Distances (cM) are shown from the most P terminal marker of the chromosome. linkage detected to marker D5S2500 (P ¼ 0.0005) located on 5q11.2. Two separate linkage peaks were clearly delineated on chromosomes 5: the first peak had the marker D5S2500 at its highest significance level (P ¼ 0.0005) and encompassed a 60 cM region spanning from 5p15.2 to 5q11.2 (Table 1 and Figure 2) ; the second peak was on chromosome 5q35 about 48 cM from the other peak with the marker D5S211 at its highest level of statistical significance (P ¼ 0.005).
Additional minor peaks were found on five other chromosomes: 1, 2, 9, 11 and 20 (see Table 1 ). The peaks on chromosomes 2p25, 9q34 and 11p15 were all of approximately the same level of significance, with Pvalues ranging from 0.01 to 0.015. The peak on chromosome 2p25 was sharper than those on 9q34 and 11p15 and is defined by an 180 cM region bordered by markers TPO and D2S2952. The other two suggestive areas for linkage on chromosomes 1p22 and 20q13 had the weakest statistical evidence for linkage among the eight regions ( Table 1 ). The peak on chromosome 20q13 was particularly ill defined, with about half of the multipoint P-values along chromosome 20 less than 0.1. A genome scan analysis that differentially weighted affected sibs with definite and highly probable disease did not appreciably change the results (data not shown). In addition, to determine the sensitivity of our results to allele frequency misspecification due to missing parental genotypes, we reanalyzed the regions with significant linkage signals using frequencies proportional to the complement of the marker allele frequencies, but found no marked change in the magnitude of the lowest P-values in each region. No linkage was detected at the MHC region of chromosome 6p despite the dense marker spacing that was used in this region.
To better understand what portion of our study sample, affected sib pairs (ASP) or discordant sib pairs (DSP), were influencing study results, we calculated mean allele sharing (p) in the 252 ASP and 149 DSP who were full-sib pairs (Table 2 and Figure 1 ) as well as the 83 ASP and 17 DSP who were half-sib pairs ( Table 2 only). Based on sharing probabilities, it appears that a majority of the significant linkage signals detected by the H-E regression were driven primarily by decreased allele sharing in DSP. For instance, at the marker with the most statistically significant linkage signal, D5S2500 (P ¼ 0.0005), ASP had a moderately increased allele sharing IBD (identity-by-descent) of 0.518, but the mean allele sharing IBD estimate for DSP at this marker was 0.444 (Po0.05). In half-sib pairs, both ASP and DSP mean allele sharing IBD estimates were significantly different than expected values for D5S2500. Significantly decreased sharing was observed in discordant full-sib pairs at D2S2952, D5S817, D5S211, ATA52D02, D9S2157 and D20S480 and in discordant half-sib pairs at D1S551 and D5S1457. Paradoxically, for the markers ATA52D02 and D20S164, the IBD allele-sharing estimate in full DSP was significantly below the null value of 0.5, but in half DSP it was significantly above the null value of 0.25. In half ASP, both D11S1999 and D20S480 had IBD estimates significantly less than the null value, which likely weakened the overall H-E regression signal for linkage at these markers. For the other markers with significant linkage results, a greater than expected allele sharing in ASP appeared to be primarily responsible for the linkage signal, in particular, D5S1457 and D11S1984, in which the estimates for p were 0.536 and 0.545, respectively.
Among ASP alone, the two most significant markers not detected by H-E regression were ATA34E08 on chromosome 11p and D17S1298 on chromosome 17p. ATA34E08 is actually on the right-hand part of the tail of the chromosome 11 linkage peak detected at 11p15 by H-E regression. In ASP, p was 0.549 (P ¼ 0.004), but p was also elevated in discordant pairs (p ¼ 0.511), which explains the lack of a significant H-E P-value. Likewise, the significant increased allele sharing among ASP at 17p for D17S1298, p ¼ 0.538 (P ¼ 0.017), was negated in the H-E regression by increased sharing of DSP at this marker, p ¼ 0.522.
We separately analyzed a subset of sib pairs in families with three or more affected sibs (Figure 3a-d) . This subset comprised about 40% of the total sib pairs (n ¼ 208 sib pairs) and about 25% of the total number of sibs (n ¼ 139). Although this subset of sib pairs had approximately the same proportion of ASPs as the larger study sample (67.8 vs 65.1%), a disproportionate number of males were in this sample (35.1 vs 26.6%). Of the eight notable linkage peaks in the full sample, most were either unchanged or decreased by a proportion consistent with having only 40% of the sample available. One linkage peak that increased markedly was on chromosome 9q34 (Figure 3c ). In the full sample, the most significant marker on chromosome 9 was D9S1825 with a P-value of 0.009. D9S2157, the adjacent marker to D9S1825 11 cM telomeric, had a P-value of 0.046. In the subset of families with three or more affected sibs, D9S2157 was the most statistically significant marker with P-value of 0.005 ( Figure 3c ). Other notable differences between the full sample and the families with three or more affected sibs subset were on chromosomes 3 ( Figure 3a ), 6 ( Figure 3b ) and 13 ( Figure 3d ). On chromosome 3p24, marker D3S3038 had a P-value of 0.016 and was part of a broad peak that extended 46 cM to D3S1285, which had a P-value of 0.03 ( Figure 3a ). In the full sample, this region was defined by two more modest distinct peaks with P-values in the range of 0.1. On chromosome 6q16 (Figure 3b ), D6S1056 had the lowest P-value, 0.03, in the families with three or more affected sibs. This pattern is in contrast to the full sample, in which the highest significance level was at 6q26 where D6S1277 had a P-value of 0.1. The most striking difference in results between the full sample and the subset of families with three or more affected sibs was observed on chromosome 13 ( Figure 3d ). In the full sample, statistical significance was not observed over the full 90 cM length of chromosome 13. In the families with three or more affected sibs, a sharp peak at D13S787 (P ¼ 0.005), on chromosome 13q12, was observed.
Discussion
We report the first genome scan for sarcoidosis in African Americans and have identified chromosome 5 as a priority region for candidate gene analysis. Schurmann et al 23 first reported that familial sarcoidosis is linked to the MHC region using seven microsatellite markers in a sample of 55 German families with 78 affected sibling pairs. For the genome-wide scan in the larger sample of 63 families reported by Schurmann et al, 14 the most prominent peak was found on the short arm of chromosome 6 (6p21-6p22) for six adjacent makers spanning a region of 16 cM including the MHC. Their most significant finding was with D6S1666 (P ¼ 0.001), which resides in the MHC class II gene region. Table 3 compares our results for the MHC region with those previously reported by Schurmann et al.
14 In our sample, we typed D6S1666 and three additional markers in a 3 cM region that spanned the MHC. We thought this dense marker coverage of the MHC was warranted given the strong linkage to sarcoidosis found in German Caucasians and the multitude of reported HLA associations with sarcoidosis including an association we previously reported between HLA-DQB1 and sarcoidosis susceptibility in a separate African-American sample. 16 We found no evidence for linkage of sarcoidosis susceptibility to the MHC region of chromosome 6p in our SAGA study population. The SAGA study did have potential agreements with the previously reported scan by Schurmann et al 14 on chromosomes 1p and 9q. A minor peak was detected with D1S551 on 1p22.3 (P ¼ 0.044). Schurmann et al, 14 detected a minor peak for D1S1665 (P ¼ 0.03) on 1p22 about 11 cM away from D1S551. We found suggestive evidence for linkage with D9S1825 on 9q34.1 (P ¼ 0.013). Schurmann et al 14 noted a minor peak for D9S934 about 8 cM telomeric to D9S1825 on 9q33.1.
In comparing the results of our genome scan with that of Schurmann et al, 14 it should be noted that our sample includes ASP, DSP and a few unaffected sib pairs (USP), whereas the sample analyzed by Schurmann et al was entirely ASP. When we restricted our analysis to only ASP, many of our linkage peaks were significantly diminished. It is also important to note that the two linkage peaks in the restricted ASP analysis that were not evident in the H-E regression (ATA34E08 on chromosome 11p and D17S1298 on chromosome 17p) appear to be due primarily to meiotic drive since DSP also had increased sharing at these loci. Therefore, it is likely that these peaks on 11p and 17p are false positives that the H-E regression technique is designed to guard against. Another point is that many of the linkage signals detected by H-E regression appear to be driven primarily by decreased sharing in DSP rather than increased sharing in ASP (Table 2 ). This suggests the possibility of protective alleles as opposed to alleles that increase disease risk. The use of discordant pair 'controls' is a distinct advantage of the H-E regression technique that, while originally developed for quantitative traits, 24 can validly be applied to binary traits such as sarcoidosis. 25 Based on our current understanding of the immunologic and molecular mechanisms leading to granuloma formation in sarcoidosis, [26] [27] [28] candidate genes might be expected to be involved in antigen processing or presentation, T-cell receptor selection, T-cell activation and apoptosis, inflammatory cell recruitment, Th1/Th2 balance or cytokine regulation. Several potential candidates in proximity to the linked markers exist. One candidate, the interleukin-6 signal transducer (IL6ST), is located midway between two linked markers, D5S1457 (P ¼ 0.011) and D5S2500 (P ¼ 0.0005), within a 9-10 MB region. IL6ST, the transmembrane glycoprotein beta subunit gp130, is a transducer chain shared by many cytokines including IL6, IL11 and leukemia inhibitory factor. 29 We and others have found that IL6 levels are elevated in the bronchoalveolar lavage (BAL) and serum obtained from sarcoidosis patients. [30] [31] [32] After D5S2500, the next most significant result was with D5S211 on 5q35.2 (P ¼ 0.005). Two patients with 5q myelodysplasia and sarcoidosis have been reported, 33, 34 suggesting that a chromosome 5q abnormality may predispose to sarcoidosis through loss of genes coding Figure 3 Chromosome 3, 6, 9 and 13 genome scan results for sarcoidosis susceptibility in African-American nuclear families ascertained through two affected sibs. Results are depicted as Àlog to the base 10 of multipoint P-values for H-E regression of full sample (solid line; n ¼ 516 sib pairs) and sample of families with three or more affected sibs (broken line; n ¼ 206 sib pairs). for T helper cell 2 cytokines, IL-4, IL-5, IL-13, and CSF2, which encodes the granulocyte macrophage colony stimulating factor. An association between Crohn's disease and sarcoidosis, both granulomatous inflammatory diseases, has been suggested. 35, 36 IBD5, a Crohn's disease (CD) susceptibility locus on 5q31-33, is 13 cM centromeric to D5S211, 37 but D5S211 is too distant to provide much support that this Crohn's locus is involved in sarcoidosis susceptibility. A major susceptibility locus for CD is located on chromosome 16 (IBD1) 38 and mutations in the leucine-rich region (LRR) of the CARD15 (NOD2) (MIM 605956) gene associated with CD have been discovered. [39] [40] [41] We previously found no evidence of linkage of this locus to sarcoidosis, 42 and Schurmann et al 35 also could not find evidence that CARD15 mutations are associated with sarcoidosis. No evidence exists for a sarcoidosis susceptibility locus on chromosome 16 in the present study (Figure 1) .
The main approach to identify susceptibility genes in sarcoidosis has been to evaluate candidate genes selected on the basis of our current understanding of the immunopathogenesis. This approach has had mixed success. A major limitation of case-control association studies of candidate genes is that an allelic association may arise if cases and controls were drawn from genetically different populations even though no disease gene association exists. Recently, in a large family-based association study Rybicki et al 43 reported lack of associations with three candidate genes for sarcoidosis that previously had positive associations in studies that used a case control design. [44] [45] [46] The initial stage of a genome scan is blind to biases toward any specific group of candidate genes; however, to guard against false negatives, liberal P-values are used for follow-up of linkage signals. In using a P-value of 0.05 to identify potentially interesting regions for follow-up, the significant SAGA study results include eight separate linkage peaks. If we use the simulation results of the locus counting method proposed by Wiltshire et al 47 for our 10 cM genome scan, our most significant P-value of 0.0005 translates into a genome-wide significance level in the range of 0.18-0.25 and our study-wide nominal P-value of 0.05 would yield an expected eight to 10 false positives. Therefore, it is highly likely that a majority of the peaks we have identified are false positives, but further fine mapping of these peaks should minimize our study-wide type I error. 48 The SAGA sib pair study sample was over five times greater than the only other genome scan conducted for sarcoidosis. While the size of the SAGA study population is a significant strength, it may also be a weakness. A total of 11 geographically diverse sites were required to ascertain and enroll over 200 affected sib pair AfricanAmerican families. A significant north-south gradient in Caucasian admixture proportions within the AfricanAmerican population is known to exist in the US. 49, 50 Since subjects enrolled into SAGA came from as far north as Michigan and as far south as South Carolina, the genetic makeup of the SAGA study sample is likely heterogeneous, making detection of significant linkage signals more difficult. In our sib pair study population, it appears that the proband who led to the ascertainment of the affected sibship had more severe disease than his or her affected sib(s). This ascertainment bias could potentially diminish our study power if genes involved in severity are also involved in susceptibility. Future analyses of the SAGA sample that will focus upon disease phenotypes should help to address this potential limitation.
In summary, our results support both intra-and interethnic locus heterogeneity for sarcoidosis susceptibility. Our subanalyses of families with three or more affecteds detected linkage signals not present in the larger sample. We also found no evidence for linkage to the MHC region in our African-American study population compared with the previous positive finding in this region reported by Schurmann et al.
14 Our genome scan replicated their suggestive linkage findings to chromosomes 1p and 9q, but the most significant linkage in our African-American sample, on chromosome 5q11, was a novel result. In this region, several strong candidates for sarcoidosis susceptibility exist. Future studies will narrow linkage peaks on 5q and search for associations between sarcoidosis and specific haplotypes within this region.
Methods

Study sample
The study protocol was reviewed and approved by the institutional review boards for human subjects research at each participating institution. As an added assurance for participants, the study obtained a certificate of confidentiality; informed consents stated that the genetic material would not be used for purposes beyond the SAGA study. Recruitment began within the pulmonary clinics of SAGA study investigators, and also included outreach to additional clinics and physicians specializing in pulmonology, dermatology, ophthalmology, and rheumatology; health fairs and local and national advertisement campaigns. Families were ascertained through two or more medically documented sarcoidosis cases who self-reported their ethnic background as black or African American. Cases with active tuberculosis, a history of primary biliary cirrhosis or chronic beryllium disease were ineligible. All affected sibs were classified as either definite or highly probable cases of sarcoidosis. Definite cases had histologic confirmation of noncaseating granulomas and disease involving either the thorax or two or more other organ systems. Highly probable cases had chest radiographs showing bilateral hilar adenopathy and either a history of erythema nodosum or at least 2 years observation during which time no other disease was found to explain radiographic abnormalities. Unaffected sibs of affected sib pairs were enrolled to serve as a control group and increase study power. Since sarcoidosis is a condition that can go undiagnosed, we carefully screened sibs who reported a negative history of sarcoidosis to increase the probability that the sib was truly unaffected. Putative unaffected sibs reporting diagnosed neuropathy, ventricular arrhythmia, cardiomyopathy, eye inflammation, hepatitis or spleen enlargement of unknown cause were considered ineligible. All unaffected sibs were required to have a normal chest radiograph within a year of enrollment. Available parents were also enrolled to supplement allele-sharing data, but in the majority of nuclear families only sibs were enrolled.
In total, 519 sib pairs from 229 nuclear families were available for analysis (Table 4) . ASP made up 65% of the sample with DSP comprising 32% and USP only 3%. Of the 519 sib pairs, half-sib pairs (n ¼ 104) made up about 20% of the sample. In total, the sample comprised 505 sibs (123 male: 382 female) with a history of sarcoidosis and 70 sibs (30 male: 40 female) with no sarcoidosis history. Both parents were genotyped for 67 sib pairs and one parent was genotyped for 98 sib pairs. Despite missing some or all parental genotype data for a majority of the sib pairs (87%), only 24% (n ¼ 122) of sib pairs were derived from sibships that had the minimal nuclear family configuration of two affected sibs with no parents. On average, even in these minimal sibships, threequarters of the missing parental genotype data can be reconstructed from the sib genotype data. Additional sib and parental data in the remaining 330 sib pairs with incomplete parental genotype data allowed even more complete imputation of these missing data. Table 5 shows the distribution of selected clinical data in affected sibs by proband status. Based on chi square tests of significance, probands were significantly more likely to have a definite sarcoidosis diagnosis, extrathoracic disease involvement and a chronic disease course. A higher proportion of probands also were treated for their sarcoidosis and had a higher radiographic Scadding stage at the time of disease presentation, but these differences were not statistically significant.
Genome scan
High molecular weight DNA was isolated from buffy coats 51 and 380 markers on 22 autosomes were genotyped. We used the Weber 10 microsatellite marker set, which has an average marker spacing of 9.18 cM. We also typed four additional markers, D6S306, D6S265, D6S16666 and D6S1701, between D6S2439 and D6S1051 to allow for dense marker coverage of the MHC region of chromosome 6p.
We used a fluorescence-based genotyping method. PCR primers conjugated with fluorescent dyes were purchased from IDT technology and Applied Biosystems. Genomic DNA (at 10 ng/ml, 3 ml) was PCR amplified using 0.225 U Platinum Taq DNA Polymerase (Gibco), Tris-HCl (200 mM, pH 8.4), dNTPs (200 mM each), MgCl 2 (1.0-3.0 mM) and forward and reverse PCR primers (0.2 mM). The final reaction volume was 12 ml and the reactions were carried out in 96-well plates on an MJ Research Tetrad DNA Engine. The amplification reactions were optimized for the fluorescent dye-labeled primers, using the published conditions as the initial value. Eight to 10 markers were pooled after PCR to create multiplexed panels. The multiplexed markers were run on an ABI 3700 capillary machine (Applied Biosystems). In all, 5% blind replicates and two Centre d'Etude du Polymorphisme Humain (CEPH) controls were included on each gel to serve as internal controls. The ABI ROX 500 standard (present in every lane) was used to estimate the size of alleles.
Model-free linkage analysis
All computer programs referred to are part of the S.A.G.E. 4.5 software suite. 52 Prior to conducting linkage analysis, assumed marker genotypes for the 380 microsatellites were checked for Mendelian inconsistencies using MARKERINFO. Inconsistencies were verified by regenotyping. After regenotyping, the few allelic inconsistencies that remained (0.85% of total) were changed to missing values. Allele frequencies were estimated by maximizing the likelihood for the data at each marker over possible allele frequencies using the Elston-Stewart algorithm 53 as implemented in FREQ. Errors in relationship specification were identified with RELTEST. 54 Multipoint IBD sharing estimates were calculated at 2-cM increments for each sibling pair with marker data using GENIBD. Then, using generalized estimating equations (GEE) to perform a weighted H-E 55 regression, linkage to the binary phenotype of interest (presence or absence of sarcoidosis) was assessed on the sample of full-sibling pairs alone, as well as the full-and half-sibling pairs combined (as described below). As implemented in SIBPAL, the H-E regression method regresses a weighted combination of the squared trait difference and squared mean-corrected trait sum on the estimated proportion of alleles shared IBD, where in the simplest case weights are chosen proportional to the inverses of the residual variances of the squared differences and sums. We used weights that also took into account the correlation of the sums and differences, as well as for the correlation of sibling pairs (option w4 in SIBPAL). As mentioned, the trait sum is mean corrected: this mean is usually calculated from the sampled population, but because our sample was collected on the basis of the presence of the desired phenotype and therefore may inflate the true population mean, we defined the correction factor to be the population prevalence of disease (B0).
In its current version, SIBPAL considers only fullsibling pairs in the trait regression. However, because of the large number of half-siblings in our sample, we chose to create a covariate that would allow for their inclusion. All pedigrees were recoded such that sibling pairs always shared two parents and could therefore be included in the analysis. Each sibling was given a covariate value of either 0 or 1 in such a way that all siblings within a full-sibship had the same value, and the difference between the covariate values was 0 for fullsibling pairs and 1 for half-sibling pairs. We were unable to use this coding scheme in only one of the 229 sibships. In that sibship, which had five half and one affected fullsib pairs, one of the half-sibs had to be dropped resulting in the removal of three affected half-sib pairs from the final analysis. Therefore, for the analyses using the H-E regression model, the analysis data set consisted of 516 sib pairs (415 full-sibling and 101 half-sibling pairs).
To evaluate the accuracy of nominally significant multipoint H-E P-values (HEP), SIBPAL was used to generate a sample of up to 100 000 replicates from the null permutation distributions of the allele sharing data for full-sibling pairs for regions that were suggestive of linkage. The permutation multipoint P-values were virtually identical to the HEP (within a factor of 1.01), therefore only HEP are reported. Permutations were performed both across sibships of the same size and within sibships to allow for a test more robust to possible population effects (eg, stratification). In addition to trait regression, in an effort to assess the contribution of each of the pair types (ASP, DSP and USP) to the linkage signal, we performed mean tests. By comparing the multipoint IBD sharing estimates (p) to the expected value of 0.5, we could assess which sib pair types were giving evidence for and against linkage. Significance was determined based on a one-sided t-test.
